242 related articles for article (PubMed ID: 14976224)
21. Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2.
Chen W; Ren XR; Nelson CD; Barak LS; Chen JK; Beachy PA; de Sauvage F; Lefkowitz RJ
Science; 2004 Dec; 306(5705):2257-60. PubMed ID: 15618519
[TBL] [Abstract][Full Text] [Related]
22. Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation.
Krasel C; Bünemann M; Lorenz K; Lohse MJ
J Biol Chem; 2005 Mar; 280(10):9528-35. PubMed ID: 15634674
[TBL] [Abstract][Full Text] [Related]
23. GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor-stimulated response.
Iacovelli L; Franchetti R; Masini M; De Blasi A
Mol Endocrinol; 1996 Sep; 10(9):1138-46. PubMed ID: 8885248
[TBL] [Abstract][Full Text] [Related]
24. Internalization and desensitization of the oxytocin receptor is inhibited by Dynamin and clathrin mutants in human embryonic kidney 293 cells.
Smith MP; Ayad VJ; Mundell SJ; McArdle CA; Kelly E; López Bernal A
Mol Endocrinol; 2006 Feb; 20(2):379-88. PubMed ID: 16179383
[TBL] [Abstract][Full Text] [Related]
25. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats.
Vinge LE; Øie E; Andersson Y; Grøgaard HK; Andersen G; Attramadal H
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2490-9. PubMed ID: 11709416
[TBL] [Abstract][Full Text] [Related]
26. Role of G protein-coupled receptor kinases on the agonist-induced phosphorylation and internalization of the follitropin receptor.
Lazari MF; Liu X; Nakamura K; Benovic JL; Ascoli M
Mol Endocrinol; 1999 Jun; 13(6):866-78. PubMed ID: 10379886
[TBL] [Abstract][Full Text] [Related]
27. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.
Ren XR; Reiter E; Ahn S; Kim J; Chen W; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1448-53. PubMed ID: 15671180
[TBL] [Abstract][Full Text] [Related]
28. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR.
Miller WE; Houtz DA; Nelson CD; Kolattukudy PE; Lefkowitz RJ
J Biol Chem; 2003 Jun; 278(24):21663-71. PubMed ID: 12668664
[TBL] [Abstract][Full Text] [Related]
29. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
[TBL] [Abstract][Full Text] [Related]
30. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation.
Kim KM; Gainetdinov RR; Laporte SA; Caron MG; Barak LS
J Biol Chem; 2005 Apr; 280(13):12774-80. PubMed ID: 15687500
[TBL] [Abstract][Full Text] [Related]
31. Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer.
Devost D; Zingg HH
J Mol Endocrinol; 2003 Dec; 31(3):461-71. PubMed ID: 14664707
[TBL] [Abstract][Full Text] [Related]
32. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.
Ménard L; Ferguson SS; Zhang J; Lin FT; Lefkowitz RJ; Caron MG; Barak LS
Mol Pharmacol; 1997 May; 51(5):800-8. PubMed ID: 9145918
[TBL] [Abstract][Full Text] [Related]
33. G protein-coupled receptor kinase 2 and beta-arrestins are recruited to FSH receptor in stimulated rat primary Sertoli cells.
Marion S; Kara E; Crepieux P; Piketty V; Martinat N; Guillou F; Reiter E
J Endocrinol; 2006 Aug; 190(2):341-50. PubMed ID: 16899567
[TBL] [Abstract][Full Text] [Related]
34. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
[TBL] [Abstract][Full Text] [Related]
35. Roles of phosphorylation-dependent and -independent mechanisms in the regulation of M1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 in hippocampal neurons.
Willets JM; Nahorski SR; Challiss RA
J Biol Chem; 2005 May; 280(19):18950-8. PubMed ID: 15743771
[TBL] [Abstract][Full Text] [Related]
36. β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.
Gatto F; Feelders R; van der Pas R; Kros JM; Dogan F; van Koetsveld PM; van der Lelij AJ; Neggers SJ; Minuto F; de Herder W; Lamberts SW; Ferone D; Hofland LJ
Endocrinology; 2013 Dec; 154(12):4715-25. PubMed ID: 24169548
[TBL] [Abstract][Full Text] [Related]
37. Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization.
Mundell SJ; Luty JS; Willets J; Benovic JL; Kelly E
Br J Pharmacol; 1998 Sep; 125(2):347-56. PubMed ID: 9786508
[TBL] [Abstract][Full Text] [Related]
38. Receptor selectivity of the cloned opossum G protein-coupled receptor kinase 2 (GRK2) in intact opossum kidney cells: role in desensitization of endogenous alpha2C-adrenergic but not serotonin 1B receptors.
Lembo PM; Ghahremani MH; Albert PR
Mol Endocrinol; 1999 Jan; 13(1):138-47. PubMed ID: 9892019
[TBL] [Abstract][Full Text] [Related]
39. Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin.
Zhang J; Ferguson SS; Law PY; Barak LS; Caron MG
J Recept Signal Transduct Res; 1999; 19(1-4):301-13. PubMed ID: 10071766
[TBL] [Abstract][Full Text] [Related]
40. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
Gimenez LE; Baameur F; Vayttaden SJ; Clark RB
Mol Pharmacol; 2015 Jun; 87(6):954-64. PubMed ID: 25784721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
